SNBOSD
TEVA icon

Security National Bank of So Dak’s Teva Pharmaceuticals TEVA Stock Holding History

Security National Bank of So Dak’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-17,385
Closed -$578K – 92
2017
Q2 		$578K Buy
17,385
+620
+4% +$19.2K 0.68% 61
2017
Q1 		$538K Buy
+16,765
New +$572K 0.64% 62

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Security National Bank of So Dak's TEVA Position: Q3 2017 in Review

Security National Bank of So Dak sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 17,385 shares — an estimated $578K sold.

Security National Bank of So Dak first reported a position in TEVA in Q1 2017 and held it in 2 quarters. The position peaked at $578K in Q2 2017. 536 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Security National Bank of So Dak reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Security National Bank of So Dak sold 17,385 Teva Pharmaceuticals shares in Q3 2017, an estimated $578K.
  • Security National Bank of So Dak first reported a position in Teva Pharmaceuticals in Q1 2017 and held it in 2 quarters.
  • Security National Bank of So Dak's Teva Pharmaceuticals position peaked at $578K in Q2 2017.
  • 536 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Security National Bank of So Dak's 13F filing for Q3 2017, filed 15 Nov 2017.